Global Nephrology and Urology Devices Market $41.8 Billion by 2031 (2025)

The global market for nephrology and urology devices estimated to reach $41.8 billion by 2031, growing at a CAGR of 5.8% over the forecast period, driven by lifestyle factors affecting metabolic disorders, and rising aging population worldwide.

• Other factors influencing the adoption of nephro-urology medical devices include: an increased number of patients diagnosed with the relevant conditions; the aging of the baby boomer population; commercialization of new techniques/procedures and the associated devices; and ability and the willingness of local healthcare systems to pay for these treatments.

Urological conditions include: kidney stone disease (urolithiasis), incontinence in men and women, benign prostate hyperplasia (BPH), prostate cancer and erectile dysfunction in men.

• Some of the devices used to treat the above conditions include: stone retrieval devices and catheters; foley urethral bladder catheters; intermittent catheters; prostatic stents; synthetic slings, and penile implants.

Nephrology concerns the diagnosis and treatment of kidney diseases, includingelectrolyte disturbances, hypertensionand renal replacement therapy (dialysis and kidney transplantation).

• Systemic conditions that affect the kidneys (such asdiabetesandautoimmune disease) and systemic problems that occur as a result of kidney problems (such asrenal osteodystrophyandhypertension) are also included in nephrology.
• The global prevalence of chronic kidney disease (CKD), especially in the elderly population, is expected to grow sharply in the future.

Nephro-urological interventions and their use has widened the role of interventional radiology in the management of renal tract pathology in spheres such as oncology and urolithiasis. Nephro-urology devices find wide applications in healthcare centers and hospitals.

BPH is a common problem among older men and is responsible for considerable disability.

• Symptomatic BPH and prostatitis affect over 100 million men worldwide, resulting in painful symptoms and lower quality of life.
• Clinical BPH is one of the most common diseases in ageing men and the most common cause of lower urinary tract symptoms (LUTS).
• The prevalence of BPH increases after the age of 40 years, with a prevalence of 8%–60% at age 90 years.
  • The incidence and prevalence of urinary stones are rising around the world, including regions that have historically had low rates of urolithiasis.
  • The prevalence of histologically diagnosed BPH increases from 8% in men aged 31-40, to 40-50% in men aged 51-60, to over 80% in men older than age 80.
    • Some data have suggested that there is decreased risk among the Asians compared to the western white population.

The global nephrology and urology devices market report provides market size ($million 2021 to 2031), market share, growth trends and forecast (CAGR%, 2025 to 2031).

The global market for nephro-urology devices segmented by product [benign prostatic hyperplasia devices (BPH catheterization ablation devices, prostatic stents, others), dialysis devices (hemodialysis, peritoneal dialysis), endoscopy devices, incontinence & pelvic organ prolapse treatment devices (sacral neuromodulation, mesh and slings, urethral inserts and pessaries), urinary stone treatment devices (lithotripters, stone retrieval baskets, ureteral stents)], and geography.

• Based on products, the dialysis devices segment accounted for the largest share of the total nephrology and urology devices market.
  • Among the dialysis devices, the hemodialysis devices sub-segment held majority of the market revenue, whereas the peritoneal dialysis sub-segment expected to witness the fastest CAGR during the coming years.
    • Recently, major innovations in devices and technology for hemodialysis vascular access care have rapidly changed the landscape. Novel endovascular devices for creation of arteriovenous fistulas may offer a solution to the barriers encountered in initiating maintenance hemodialysis with a permanent vascular access rather than a central venous catheter (CVC).
      • The US Data Renal System (USRDS) reports that, for 86.9% of all incident patients with kidney failure, hemodialysis remains the chosen treatment modality and that 80% initiate hemodialysis with a dialysis catheter.
    • The innovative solutions to treat stenosed and occluded thoracic central veins can provide an approach to creating a vascular access and allow patients with exhausted vasculature to remain on hemodialysis.
      • The robust developments in hemodialysis vascular access are likely to change practice patterns in the near future.
• The BPH devices segment expected to be the fastest growing segment throughout the forecast period, attributed to increasing uptake of catheterization ablation for the treatment of BPH [e.g. direct current (DC) ablation technology].
  • The urology device market involves devices used for treating BPH and urinary incontinence, and also envelopes urology endoscopes.
    • The BPH therapeutic devices market comprised of RF ablation, microwave thermotherapy, and interstitial laser coagulation devices, as well as permanent urethral stents.
      • BPH represents a lucrative global market for pharma companies, device and implant manufacturers, contract research organization (CROs) and more.

The global nephrology and urology devices market research report is further divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA) and Rest of the World.

• In terms of geography, the Europe region closely followed by North America region dominated the global market, owing to increasing adoption of advanced minimally and non-invasive technologies with superior efficacy, reduced recovery time, low cost of treatment and duration of pain.
  • For instance, in the United States, hemodialysis remains the most common treatment modality for kidney failure, chosen by almost 90% of incident patients.
  • Other factors boosting the market growth in developed regions include favorable reimbursement policies leading to increased demand of intermittent catheters used in treatment of various urology diseases such as incontinence, BPH and post operative urinary retention.
• On the other hand, the Asia Pacific market anticipated to register the fastest growth rate during the forecast period, due to increasing incidence of chronic kidney diseases coupled with rising aging population in the developing region, lower treatment cost, and improving healthcare infrastructure.

The global nephrology and urology devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major competitors operating in the global nephro-urology devices market and included in this report are Asahi Kasei Corporation, B. Braun Group, Baxter International, Inc., Becton Dickinson and Company (C. R. Bard, Inc.), Cook Group, Inc., Dornier MedTech GmbH, Fresenius Medical Care AG & Co. KGaA , Nikkiso Co. Ltd., Nipro Corporation, NxStage Medical, Inc., Rockwell Medical, Inc., and Terumo Corporation.

• Product
  • Benign Prostatic Hyperplasia Devices
    • BPH Catheterization Ablation Devices
    • Prostatic Stents
    • Other BPH devices
  • Dialysis Devices
    • Hemodialysis Devices
    • Peritoneal Dialysis Devices
  • Endoscopy Devices
  • Incontinence & Pelvic Organ Prolapse Treatment Devices
    • Sacral Neuromodulation Devices
    • Mesh and Slings
    • Urethral Inserts and Pessaries
  • Urinary Stone Treatment Devices
    • Lithotripters
    • Stone Retrieval Baskets
    • Ureteral Stents
• Geography
  • North America (U.S., Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
  • Asia Pacific (Japan, China, India, Rest of APAC)
  • Latin America (Brazil, Mexico, Rest of LA)
  • Rest of the World
• Company Profiles
  • Asahi Kasei Corporation
  • B. Braun Group
  • Baxter International, Inc.
  • Becton Dickinsonand Company (C. R. Bard, Inc.)
  • Cook Group, Inc.
  • Dornier MedTech GmbH
  • Fresenius Medical Care AG & Co. KGaA
  • Nikkiso Co. Ltd.
  • Nipro Corporation
  • NxStage Medical, Inc.
  • Rockwell Medical, Inc.
  • Terumo Corporation

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/nephrology-and-urology-devices-market/

Related publications:

• Global Dialysis Products and Services Market $189 Billion by 2029
• Dialysis Products and Services Market by Product [Hemodialysis Products (Hemodialysis Machines, Hemodialysis Dialyzers, Hemodialysis Access Products / Catheters, Hemodialysis Bloodlines, Hemodialysis Concentrates/Dialysate, Others (Water Treatment System, Fistula Needles), Peritoneal Dialysis Products (Peritoneal Concentrates / Dialysate, Peritoneal Dialysis Machines, Peritoneal Dialysis Catheters, Peritoneal Dialysis Transfer Sets), and Service (In-Center Dialysis, Home Dialysis) and Forecast 2024-2031
• Hemodialysis and Peritoneal Dialysis Market by Product [Device (Machine, Dialyzers, Water Treatment System, Others), Consumables (Bloodlines, Concentrates, Catheters, Others), Service], Type [Hemodialysis (Conventional, Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis, Automated Peritoneal Dialysis)], End User (Home-based, Hospital-based) and Forecast 2024-2031
• Global BPH Treatment Devices Market $1.1 Billion by 2029